Baolingbao Biology Co.,Ltd. (002286.SZ)
CNY 9.22
(10.02%)
CNY 9.22
(10.02%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 293.33 Million CNY | -42.01% |
| 2022 | 505.8 Million CNY | 26.11% |
| 2021 | 401.08 Million CNY | 70.43% |
| 2020 | 235.33 Million CNY | -51.97% |
| 2019 | 490 Million CNY | -1.8% |
| 2018 | 499 Million CNY | 91.59% |
| 2017 | 260.45 Million CNY | 90.59% |
| 2016 | 136.65 Million CNY | 3.8% |
| 2015 | 131.65 Million CNY | 72.88% |
| 2014 | 76.15 Million CNY | -21.21% |
| 2013 | 96.65 Million CNY | -33.15% |
| 2012 | 144.59 Million CNY | -14.38% |
| 2011 | 168.86 Million CNY | -26.77% |
| 2010 | 230.59 Million CNY | -37.33% |
| 2009 | 367.97 Million CNY | -16.46% |
| 2008 | 440.47 Million CNY | 25.5% |
| 2007 | 350.97 Million CNY | 25.1% |
| 2006 | 280.56 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 330.24 Million CNY | -18.73% |
| 2024 Q1 | 397.5 Million CNY | 35.51% |
| 2024 Q2 | 406.58 Million CNY | 2.28% |
| 2023 Q2 | 515.55 Million CNY | 4.98% |
| 2023 Q4 | 293.33 Million CNY | -23.48% |
| 2023 Q1 | 491.11 Million CNY | -2.91% |
| 2023 FY | 293.33 Million CNY | -42.01% |
| 2023 Q3 | 383.34 Million CNY | -25.64% |
| 2022 Q2 | 710.15 Million CNY | 11.36% |
| 2022 Q4 | 505.8 Million CNY | -5.95% |
| 2022 Q3 | 537.79 Million CNY | -24.27% |
| 2022 FY | 505.8 Million CNY | 26.11% |
| 2022 Q1 | 637.69 Million CNY | 58.99% |
| 2021 Q1 | 293.36 Million CNY | 24.66% |
| 2021 FY | 401.08 Million CNY | 70.43% |
| 2021 Q4 | 401.08 Million CNY | 6.76% |
| 2021 Q3 | 375.69 Million CNY | 19.9% |
| 2021 Q2 | 313.33 Million CNY | 6.81% |
| 2020 Q4 | 235.33 Million CNY | 0.16% |
| 2020 Q2 | 254.95 Million CNY | -38.57% |
| 2020 Q3 | 234.95 Million CNY | -7.84% |
| 2020 FY | 235.33 Million CNY | -51.97% |
| 2020 Q1 | 415 Million CNY | -15.31% |
| 2019 Q4 | 490 Million CNY | -19.67% |
| 2019 Q2 | 770 Million CNY | 24.39% |
| 2019 FY | 490 Million CNY | -1.8% |
| 2019 Q1 | 619 Million CNY | 24.05% |
| 2019 Q3 | 610 Million CNY | -20.78% |
| 2018 Q4 | 499 Million CNY | 42.25% |
| 2018 Q3 | 350.79 Million CNY | -10.51% |
| 2018 Q2 | 391.99 Million CNY | 23.32% |
| 2018 FY | 499 Million CNY | 91.59% |
| 2018 Q1 | 317.85 Million CNY | 22.04% |
| 2017 Q1 | 126.65 Million CNY | -7.32% |
| 2017 FY | 260.45 Million CNY | 90.59% |
| 2017 Q3 | 195.45 Million CNY | 13.86% |
| 2017 Q2 | 171.65 Million CNY | 35.53% |
| 2017 Q4 | 260.45 Million CNY | 33.26% |
| 2016 FY | 136.65 Million CNY | 3.8% |
| 2016 Q4 | 136.65 Million CNY | -6.82% |
| 2016 Q3 | 146.65 Million CNY | 0.0% |
| 2016 Q2 | 146.65 Million CNY | -3.3% |
| 2016 Q1 | 151.65 Million CNY | 15.19% |
| 2015 Q1 | 130.15 Million CNY | 70.91% |
| 2015 FY | 131.65 Million CNY | 72.88% |
| 2015 Q4 | 131.65 Million CNY | -15.69% |
| 2015 Q2 | 220.15 Million CNY | 69.15% |
| 2015 Q3 | 156.15 Million CNY | -29.07% |
| 2014 Q3 | 76.15 Million CNY | 0.0% |
| 2014 FY | 76.15 Million CNY | -21.21% |
| 2014 Q4 | 76.15 Million CNY | 0.0% |
| 2014 Q2 | 76.15 Million CNY | -0.65% |
| 2014 Q1 | 76.65 Million CNY | -20.69% |
| 2013 Q2 | 115.79 Million CNY | -17.05% |
| 2013 Q3 | 90.79 Million CNY | -21.59% |
| 2013 Q4 | 96.65 Million CNY | 6.46% |
| 2013 FY | 96.65 Million CNY | -33.15% |
| 2013 Q1 | 139.59 Million CNY | -3.46% |
| 2012 Q3 | 154.59 Million CNY | -22.93% |
| 2012 Q1 | 145.59 Million CNY | -13.78% |
| 2012 Q2 | 200.59 Million CNY | 37.78% |
| 2012 Q4 | 144.59 Million CNY | -6.47% |
| 2012 FY | 144.59 Million CNY | -14.38% |
| 2011 Q4 | 168.86 Million CNY | -15.09% |
| 2011 Q1 | 239.59 Million CNY | 3.9% |
| 2011 Q2 | 207.86 Million CNY | -13.24% |
| 2011 FY | 168.86 Million CNY | -26.77% |
| 2011 Q3 | 198.86 Million CNY | -4.33% |
| 2010 Q1 | 381.59 Million CNY | 3.7% |
| 2010 Q4 | 230.59 Million CNY | -24.05% |
| 2010 FY | 230.59 Million CNY | -37.33% |
| 2010 Q3 | 303.59 Million CNY | -4.56% |
| 2010 Q2 | 318.09 Million CNY | -16.64% |
| 2009 Q2 | 435.97 Million CNY | 0.0% |
| 2009 Q3 | 483.17 Million CNY | 10.83% |
| 2009 Q4 | 367.97 Million CNY | -23.84% |
| 2009 FY | 367.97 Million CNY | -16.46% |
| 2008 FY | 440.47 Million CNY | 25.5% |
| 2008 Q4 | 440.47 Million CNY | 0.0% |
| 2007 FY | 350.97 Million CNY | 25.1% |
| 2006 FY | 280.56 Million CNY | 0.0% |